FFCD-1004 Clinical Trial: Impact of Cytidine Deaminase Activity on Clinical Outcome in Gemcitabine-Monotherapy Treated Patients
about
FFCD-1004 Clinical Trial: Impact of Cytidine Deaminase Activity on Clinical Outcome in Gemcitabine-Monotherapy Treated Patients
description
2015 nî lūn-bûn
@nan
2015 թուականին հրատարակուած գիտական յօդուած
@hyw
2015 թվականին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
FFCD-1004 Clinical Trial: Impa ...... e-Monotherapy Treated Patients
@ast
FFCD-1004 Clinical Trial: Impa ...... e-Monotherapy Treated Patients
@en
FFCD-1004 Clinical Trial: Impa ...... e-Monotherapy Treated Patients
@nl
type
label
FFCD-1004 Clinical Trial: Impa ...... e-Monotherapy Treated Patients
@ast
FFCD-1004 Clinical Trial: Impa ...... e-Monotherapy Treated Patients
@en
FFCD-1004 Clinical Trial: Impa ...... e-Monotherapy Treated Patients
@nl
prefLabel
FFCD-1004 Clinical Trial: Impa ...... e-Monotherapy Treated Patients
@ast
FFCD-1004 Clinical Trial: Impa ...... e-Monotherapy Treated Patients
@en
FFCD-1004 Clinical Trial: Impa ...... e-Monotherapy Treated Patients
@nl
P2093
P2860
P1433
P1476
FFCD-1004 Clinical Trial: Impa ...... e-Monotherapy Treated Patients
@en
P2093
Abakar Abakar-Mahamat
Carole Montérymard
Cindy Serdjebi
Côme Lepage
Dominique Arsene
Eric François
Francine Fein
Gaël Deplanque
Jean-François Seitz
Jean-Louis Legoux
P2860
P304
P356
10.1371/JOURNAL.PONE.0135907
P407
P50
P577
2015-01-01T00:00:00Z